Based on data collected from different sources by our team,
there are indicators that suggest that this company is no longer active. However, this information may not be accurate.
If you believe this information should be updated, please .
For more details, you can read our .
CanOmix develops science-based technologies designed to bring increased accuracy, efficiency, and safety to medical cannabis cultivation. CanOmix has developed genetic markers to identify the medical potential of cannabis plants. These markers are integrated into the company's cannabis-breeding technology, leading to savings in time, money, space, and manpower. The company's R&D center, located in Israel, collaborates with academic and commercial partners worldwide.